Septic arthritis in rheumatoid disease.

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Septic arthritis in rheumatoid disease.

Abstract

References

Review of septic arthritis throughout the antibiotic era.

Antibacterial activity of synovial fluid during therapy of septic arthritis

Length of life and cause of death in rheumatoid arthritis

Suppurative arthritis complicating rheumatoid arthritis

COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT

Citations

Septic polyarthritis due to bacteroides fragilis in a patient with rheumatoid arthritis

Interaction of circulating immune complexes with granulocyte function in patients with rheumatoid arthritis

Non-gonococcal infectious arthritis: a retrospective study

Pyogenic arthritis presenting as a ruptured popliteal cyst

Improved method of isolating bacteria from joint fluids by the use of blood culture bottles

Human infection with Streptococcus zooepidemicus (Lancefield group C): three case reports

Septic arthritis due to Bacteroides fragilis in a wrist affected by rheumatoid arthritis

Pyogenic arthritis due to bacteroides complicating rheumatoid arthritis

Related Concepts

Related Feeds

CRISPR & Staphylococcus

Related Papers

Complications of juvenile chronic arthritis. Surgical treatment of septic arthritis is superior

Septic arthritis caused by Serratia marcescens

Pulmonary lesions in rheumatoid arthritis

Multiple nodules in juvenile chronic polyarthritis

Pulmonary nodules in rheumatoid arthritis